Childrens Health Care
Childrens Health Care was paid $99.95M by Medicaid between Jan 2018 and Dec 2024, across 226 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
MINNEAPOLIS, MN 55404
Next to other Psychiatric Hospital Unit providers in Minnesota
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 121,324 | $4.37M | |
| 2019 | 116,223 | $13.77M | |
| 2020 | 94,542 | $9.37M | |
| 2021 | 187,552 | $17.96M | |
| 2022 | 201,335 | $21.03M | |
| 2023 | 159,077 | $18.05M | |
| 2024incomplete | 123,501 | $15.39M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 188,634 | 182,073 | $33.23M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 66,250 | 63,139 | $18.19M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 15% | 161,083 | 150,573 | $15.42M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 6.7% | 49,662 | 47,943 | $6.65M |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3.7% | 7,709 | 6,765 | $3.68M |
| D7140 | Extraction, erupted tooth or exposed root | 3.0% | 2,667 | 874 | $2.99M |
| 0240U | 1.8% | 13,119 | 12,835 | $1.77M | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.5% | 20,811 | 20,155 | $1.47M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 20,558 | 19,965 | $1.40M |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.1% | 52,925 | 51,207 | $1.11M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.1% | 16,959 | 15,712 | $1.11M |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 11,441 | 2,231 | $988K |
214 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 8,862 | $970K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 1,004 | $906K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 44,571 | $903K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 2,428 | $902K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 9,094 | $727K |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | <1% | 2,015 | $670K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 8,858 | $646K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 8,650 | $421K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 527 | $391K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,779 | $357K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 720 | $260K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 80 | $257K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 3,251 | $247K |
| 76770 | <1% | 2,174 | $202K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 19,757 | $201K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 281 | $180K |
| D1510 | <1% | 178 | $178K | |
| 90670 | <1% | 4,416 | $175K | |
| 92610 | <1% | 2,192 | $158K | |
| 90837 | Psychotherapy session, about an hour | <1% | 1,230 | $126K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,452 | $120K |
| 94060 | <1% | 981 | $119K | |
| 92551 | <1% | 3,544 | $114K | |
| 80050 | General health panel | <1% | 3,120 | $112K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 606 | $110K |
| D2933 | <1% | 1,200 | $104K | |
| 93325 | <1% | 6,088 | $102K | |
| 97802 | <1% | 1,462 | $99K | |
| 74019 | <1% | 2,273 | $98K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,179 | $93K |
| 95782 | <1% | 128 | $91K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 6,099 | $90K |
| 97166 | <1% | 1,009 | $88K | |
| 90686 | <1% | 22,681 | $85K | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 2,549 | $80K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 201 | $78K |
| 36415 | Collection of venous blood by venipuncture | <1% | 41,976 | $78K |
| 93320 | <1% | 2,451 | $75K | |
| 74018 | <1% | 1,961 | $66K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 959 | $63K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 21,817 | $55K |
| 36591 | <1% | 1,214 | $52K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,084 | $50K |
| 90480 | <1% | 1,224 | $45K | |
| 80061 | Lipid panel | <1% | 3,365 | $45K |
| 96127 | <1% | 1,870 | $44K | |
| D1120 | Dental cleaning, child | <1% | 2,209 | $44K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,030 | $42K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,666 | $40K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,111 | $32K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 13,988 | $31K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 873 | $28K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 813 | $28K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 841 | $28K |
| 42830 | <1% | 13 | $27K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 424 | $25K |
| 99188 | <1% | 994 | $25K | |
| 90677 | <1% | 696 | $25K | |
| G0378 | Hospital observation service, per hour | <1% | 220 | $24K |
| 90723 | <1% | 2,769 | $22K | |
| 97803 | <1% | 348 | $21K | |
| 94664 | <1% | 190 | $21K | |
| 0002A | <1% | 542 | $20K | |
| 0072A | <1% | 685 | $20K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 1,694 | $20K |
| 36430 | <1% | 66 | $19K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 389 | $19K |
| 90651 | <1% | 1,140 | $17K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,422 | $15K |
| 84439 | <1% | 5,563 | $15K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 154 | $14K |
| 90734 | <1% | 426 | $13K | |
| 0001A | <1% | 410 | $13K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 126 | $13K |
| D1206 | Topical application of fluoride varnish | <1% | 592 | $11K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 115 | $11K |
| 87631 | <1% | 1,092 | $11K | |
| 0071A | <1% | 326 | $10K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 149 | $10K |
| 99173 | <1% | 856 | $10K | |
| 83655 | <1% | 1,291 | $8K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 54 | $8K |
| D2332 | <1% | 21 | $8K | |
| 97165 | <1% | 115 | $7K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 53 | $7K |
| 82728 | <1% | 1,542 | $7K | |
| 95012 | <1% | 772 | $7K | |
| 85055 | <1% | 539 | $6K | |
| 85045 | <1% | 4,773 | $6K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 129 | $6K |
| 84460 | <1% | 2,338 | $5K | |
| 85018 | <1% | 3,682 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 78 | $5K |
| 82947 | <1% | 1,224 | $4K | |
| 93226 | <1% | 51 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,416 | $4K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 11,503 | $4K |
| 90681 | <1% | 275 | $4K | |
| 64450 | <1% | 14 | $4K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 14 | $4K |
| 88261 | <1% | 13 | $3K | |
| D1351 | Sealant - per tooth | <1% | 273 | $3K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 117 | $3K |
| 93296 | <1% | 104 | $3K | |
| 96409 | <1% | 21 | $3K | |
| 86902 | <1% | 52 | $2K | |
| 29705 | <1% | 12 | $2K | |
| 96158 | <1% | 33 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 8,634 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,466 | $2K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 29 | $2K |
| 87040 | <1% | 553 | $2K | |
| 0124A | <1% | 74 | $2K | |
| 96161 | <1% | 24 | $2K | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 425 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 27 | $2K |
| 88230 | <1% | 14 | $2K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 1,370 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,308 | $1K |
| 93321 | <1% | 81 | $1K | |
| 0054A | <1% | 34 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 27 | $1K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 15 | $1K |
| 81025 | <1% | 474 | $1K | |
| 73090 | <1% | 28 | $1K | |
| 97167 | <1% | 13 | $1K | |
| 86140 | <1% | 826 | $1K | |
| D2929 | <1% | 94 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 7,487 | $1K |
| 70360 | <1% | 12 | $987.43 | |
| 83020 | <1% | 364 | $984.85 | |
| 77072 | <1% | 13 | $950.66 | |
| 82565 | <1% | 512 | $950.25 | |
| 99285 | Emergency room visit (most serious) | <1% | 15 | $875.36 |
| 80053 | Comprehensive metabolic panel | <1% | 263 | $781.46 |
| 0004A | <1% | 35 | $768.08 | |
| 74022 | <1% | 13 | $748.12 | |
| 80069 | <1% | 116 | $697.23 | |
| 82465 | <1% | 234 | $634.95 | |
| 0082A | <1% | 24 | $631.50 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 13 | $604.53 |
| 84481 | <1% | 140 | $580.05 | |
| J3490 | Unclassified drugs | <1% | 197 | $567.27 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 334 | $560.93 |
| 83001 | <1% | 65 | $554.62 | |
| 83002 | <1% | 65 | $543.81 | |
| 88300 | <1% | 95 | $529.28 | |
| 87536 | <1% | 42 | $513.46 | |
| 73100 | <1% | 15 | $496.00 | |
| 84478 | <1% | 120 | $463.58 | |
| 0081A | <1% | 17 | $433.19 | |
| 73070 | <1% | 28 | $424.57 | |
| 96136 | <1% | 12 | $377.17 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,766 | $368.21 |
| 85027 | <1% | 160 | $353.78 | |
| 86923 | <1% | 13 | $345.30 | |
| 86360 | <1% | 40 | $342.35 | |
| 86850 | <1% | 67 | $330.48 | |
| 84305 | <1% | 73 | $323.70 | |
| 90656 | <1% | 1,167 | $319.17 | |
| 84450 | <1% | 59 | $268.79 | |
| 86359 | <1% | 40 | $262.36 | |
| 82570 | <1% | 146 | $262.04 | |
| 91300 | <1% | 120 | $237.15 | |
| 0074A | <1% | 12 | $236.82 | |
| 70250 | <1% | 14 | $225.22 | |
| 82670 | <1% | 13 | $191.65 | |
| 91321 | <1% | 437 | $186.87 | |
| 86900 | <1% | 67 | $176.97 | |
| 83520 | <1% | 58 | $161.69 | |
| 84100 | <1% | 191 | $161.63 | |
| 84252 | <1% | 13 | $157.17 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 29 | $155.24 |
| 96137 | <1% | 12 | $150.41 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,206 | $150.23 |
| 82248 | <1% | 81 | $136.21 | |
| 82784 | <1% | 30 | $133.23 | |
| J9370 | Vincristine sulfate, 1 mg | <1% | 12 | $126.48 |
| 86901 | <1% | 67 | $121.29 | |
| 82043 | <1% | 65 | $121.16 | |
| 90474 | <1% | 13 | $120.38 | |
| 85660 | <1% | 31 | $100.69 | |
| 83735 | <1% | 65 | $98.75 | |
| 84403 | <1% | 15 | $87.56 | |
| 84402 | <1% | 14 | $86.54 | |
| 81001 | <1% | 253 | $82.69 | |
| 82247 | <1% | 54 | $70.82 | |
| 84156 | <1% | 52 | $55.88 | |
| 83550 | <1% | 26 | $53.10 | |
| 82962 | <1% | 13 | $51.10 | |
| 83690 | <1% | 44 | $47.82 | |
| 83516 | <1% | 16 | $46.68 | |
| 83615 | <1% | 16 | $43.20 | |
| 83540 | <1% | 27 | $39.30 | |
| 85007 | <1% | 51 | $38.90 | |
| 82550 | <1% | 44 | $37.17 | |
| 81003 | <1% | 103 | $36.96 | |
| 82657 | <1% | 38 | $34.56 | |
| 82533 | <1% | 16 | $32.80 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,165 | $17.53 |
| 91322 | <1% | 77 | $17.44 | |
| 86003 | <1% | 27 | $17.40 | |
| 86141 | <1% | 13 | $15.85 | |
| 85652 | <1% | 12 | $9.12 | |
| 82785 | <1% | 27 | $3.79 | |
| 90710 | <1% | 46 | $0.02 | |
| 90647 | 0% | 2,660 | $0.00 | |
| 90696 | 0% | 20 | $0.00 | |
| 87807 | 0% | 12 | $0.00 | |
| 87081 | 0% | 15 | $0.00 | |
| 90633 | 0% | 900 | $0.00 | |
| 90715 | 0% | 136 | $0.00 | |
| 90691 | 0% | 13 | $0.00 | |
| 96159 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Childrens Health Care | Minneapolis, MN | $25.45M |
| Childrens Health Care | Minneapolis, MN | $18.63M |
| Children's Health Care | Minneapolis, MN | $17.32M |
| Children's Clinic Network | Maple Grove, MN | $9.97M |
| Childrens Health Care | Minneapolis, MN | $2.88M |
| Children's Clinic Network | Edina, MN | $2.88M |
| Children's Health Care | Minneapolis, MN | $2.50M |
| Children's Health Care | Minneapolis, MN | $2.43M |
| Children's Clinic Network | West St Paul, MN | $2.37M |
| Childrens Health Care | Minneapolis, MN | $1.96M |
| Childrens Health Care Services INC | Minnetonka, MN | $792K |
| Childrens Health Care | Minneapolis, MN | $557K |
| Children's Clinic Network | Hugo, MN | $453K |
| Children's Health Care | Minneapolis, MN | $397K |
| Children's Health Care | Minneapolis, MN | $120K |
| Childrens Health Care Services INC | Minnetonka, MN | $64K |
| Children's Health Care | Minneapolis, MN | $48K |
| Children's Health Care | Minneapolis, MN | $43K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.